ARF1 and CHRM3 |
ADP ribosylation factor 1 |
cholinergic receptor muscarinic 3 |
- Synthesis of PIPs at the plasma membrane
- Synthesis of PIPs at the Golgi membrane
- Nef Mediated CD4 Down-regulation
- trans-Golgi Network Vesicle Budding
- MHC class II antigen presentation
- Lysosome Vesicle Biogenesis
- Golgi Associated Vesicle Biogenesis
- COPI-mediated anterograde transport
- COPI-dependent Golgi-to-ER retrograde traffic
- Intra-Golgi traffic
- Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
|
- Muscarinic acetylcholine receptors
- Acetylcholine regulates insulin secretion
- G alpha (q) signalling events
|
- 1,3-Propandiol
- Guanosine-3'-Monophosphate-5'-Diphosphate
- Guanosine-5'-Triphosphate
- Guanosine-5'-Diphosphate
- Brefeldin A
- Myristic acid
- Glycerin
|
- Cevimeline
- Tramadol
- Succinylcholine
- Ziprasidone
- Disopyramide
- Amitriptyline
- Ipratropium bromide
- Olanzapine
- Metixene
- Terfenadine
- Clozapine
- Trihexyphenidyl
- Oxyphencyclimine
- Procyclidine
- Loxapine
- Carbachol
- Promazine
- Hyoscyamine
- Cyproheptadine
- Pethidine
- Imipramine
- Methylscopolamine bromide
- Chlorpromazine
- Darifenacin
- Tridihexethyl
- Anisotropine Methylbromide
- Nortriptyline
- Amoxapine
- Cinnarizine
- Atropine
- Thiopental
- Nicardipine
- Paroxetine
- Homatropine Methylbromide
- Trimipramine
- Diphemanil Methylsulfate
- Scopolamine
- Benzquinamide
- Propiomazine
- Cryptenamine
- Tropicamide
- Brompheniramine
- Maprotiline
- Glycopyrronium
- Bethanechol
- Tolterodine
- Oxybutynin
- Promethazine
- Pilocarpine
- Doxepin
- Desipramine
- Ketamine
- Quetiapine
- Mivacurium
- Diphenidol
- Aripiprazole
- Chlorprothixene
- Pancuronium
- Pipecuronium
- Methotrimeprazine
- Tiotropium
- Solifenacin
- Isopropamide
- Acetylcholine
- Arecoline
- Mepenzolate
- Itopride
- ALKS 27
- Fesoterodine
- Methacholine
- Hexocyclium
- Aclidinium
- Umeclidinium
- Dosulepin
- Etoperidone
- Imidafenacin
- Butylscopolamine
- Dexpanthenol
|
|
|
ARF1 and ASAP2 |
ADP ribosylation factor 1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
- Synthesis of PIPs at the plasma membrane
- Synthesis of PIPs at the Golgi membrane
- Nef Mediated CD4 Down-regulation
- trans-Golgi Network Vesicle Budding
- MHC class II antigen presentation
- Lysosome Vesicle Biogenesis
- Golgi Associated Vesicle Biogenesis
- COPI-mediated anterograde transport
- COPI-dependent Golgi-to-ER retrograde traffic
- Intra-Golgi traffic
- Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
|
|
- 1,3-Propandiol
- Guanosine-3'-Monophosphate-5'-Diphosphate
- Guanosine-5'-Triphosphate
- Guanosine-5'-Diphosphate
- Brefeldin A
- Myristic acid
- Glycerin
|
|
|
|
ARL4D and SNRPN |
ADP ribosylation factor like GTPase 4D |
small nuclear ribonucleoprotein polypeptide N |
|
- mRNA Splicing - Major Pathway
|
|
|
|
- Prader-Willi and Angelman syndromes, including: Angelman syndrome (AS); Prader-Willi syndrome (PWS)
|
ARL4D and EML4 |
ADP ribosylation factor like GTPase 4D |
EMAP like 4 |
|
- EML4 and NUDC in mitotic spindle formation
|
|
|
|
- Non-small cell lung cancer
|
ARF5 and ASAP2 |
ADP ribosylation factor 5 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
- COPI-mediated anterograde transport
- COPI-dependent Golgi-to-ER retrograde traffic
|
|
|
|
|
|
ARF6 and CHRM3 |
ADP ribosylation factor 6 |
cholinergic receptor muscarinic 3 |
- TBC/RABGAPs
- Clathrin-mediated endocytosis
- MET receptor recycling
|
- Muscarinic acetylcholine receptors
- Acetylcholine regulates insulin secretion
- G alpha (q) signalling events
|
- 5'-Guanosine-Diphosphate-Monothiophosphate
- Guanosine-5'-Diphosphate
- Myristic acid
|
- Cevimeline
- Tramadol
- Succinylcholine
- Ziprasidone
- Disopyramide
- Amitriptyline
- Ipratropium bromide
- Olanzapine
- Metixene
- Terfenadine
- Clozapine
- Trihexyphenidyl
- Oxyphencyclimine
- Procyclidine
- Loxapine
- Carbachol
- Promazine
- Hyoscyamine
- Cyproheptadine
- Pethidine
- Imipramine
- Methylscopolamine bromide
- Chlorpromazine
- Darifenacin
- Tridihexethyl
- Anisotropine Methylbromide
- Nortriptyline
- Amoxapine
- Cinnarizine
- Atropine
- Thiopental
- Nicardipine
- Paroxetine
- Homatropine Methylbromide
- Trimipramine
- Diphemanil Methylsulfate
- Scopolamine
- Benzquinamide
- Propiomazine
- Cryptenamine
- Tropicamide
- Brompheniramine
- Maprotiline
- Glycopyrronium
- Bethanechol
- Tolterodine
- Oxybutynin
- Promethazine
- Pilocarpine
- Doxepin
- Desipramine
- Ketamine
- Quetiapine
- Mivacurium
- Diphenidol
- Aripiprazole
- Chlorprothixene
- Pancuronium
- Pipecuronium
- Methotrimeprazine
- Tiotropium
- Solifenacin
- Isopropamide
- Acetylcholine
- Arecoline
- Mepenzolate
- Itopride
- ALKS 27
- Fesoterodine
- Methacholine
- Hexocyclium
- Aclidinium
- Umeclidinium
- Dosulepin
- Etoperidone
- Imidafenacin
- Butylscopolamine
- Dexpanthenol
|
|
|
ARF6 and ASAP2 |
ADP ribosylation factor 6 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
- TBC/RABGAPs
- Clathrin-mediated endocytosis
- MET receptor recycling
|
|
- 5'-Guanosine-Diphosphate-Monothiophosphate
- Guanosine-5'-Diphosphate
- Myristic acid
|
|
|
|
RHOA and ARNTL |
ras homolog family member A |
aryl hydrocarbon receptor nuclear translocator like |
- GPVI-mediated activation cascade
- Axonal growth inhibition (RHOA activation)
- Rho GTPase cycle
- PI3K/AKT activation
- Axonal growth stimulation
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- G beta:gamma signalling through PI3Kgamma
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- EPHA-mediated growth cone collapse
- EPHA-mediated growth cone collapse
- PCP/CE pathway
- G alpha (12/13) signalling events
- Sema4D mediated inhibition of cell attachment and migration
- Sema4D induced cell migration and growth-cone collapse
- Sema4D induced cell migration and growth-cone collapse
- VEGFA-VEGFR2 Pathway
- RHO GTPases activate PKNs
- RHO GTPases activate CIT
- RHO GTPases activate CIT
- RHO GTPases activate KTN1
- RHO GTPases Activate ROCKs
- RHO GTPases Activate ROCKs
- RHO GTPases Activate Formins
- RHO GTPases Activate Rhotekin and Rhophilins
- RHO GTPases Activate Rhotekin and Rhophilins
- Ovarian tumor domain proteases
- ERBB2 Regulates Cell Motility
- Neutrophil degranulation
- PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
- SLIT2:ROBO1 increases RHOA activity
|
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- PPARA activates gene expression
- Circadian Clock
|
|
|
|
|
RHOA and NOTCH1 |
ras homolog family member A |
notch receptor 1 |
- GPVI-mediated activation cascade
- Axonal growth inhibition (RHOA activation)
- Rho GTPase cycle
- PI3K/AKT activation
- Axonal growth stimulation
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- G beta:gamma signalling through PI3Kgamma
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- EPHA-mediated growth cone collapse
- EPHA-mediated growth cone collapse
- PCP/CE pathway
- G alpha (12/13) signalling events
- Sema4D mediated inhibition of cell attachment and migration
- Sema4D induced cell migration and growth-cone collapse
- Sema4D induced cell migration and growth-cone collapse
- VEGFA-VEGFR2 Pathway
- RHO GTPases activate PKNs
- RHO GTPases activate CIT
- RHO GTPases activate CIT
- RHO GTPases activate KTN1
- RHO GTPases Activate ROCKs
- RHO GTPases Activate ROCKs
- RHO GTPases Activate Formins
- RHO GTPases Activate Rhotekin and Rhophilins
- RHO GTPases Activate Rhotekin and Rhophilins
- Ovarian tumor domain proteases
- ERBB2 Regulates Cell Motility
- Neutrophil degranulation
- PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
- SLIT2:ROBO1 increases RHOA activity
|
- Pre-NOTCH Processing in the Endoplasmic Reticulum
- Pre-NOTCH Transcription and Translation
- Pre-NOTCH Transcription and Translation
- Pre-NOTCH Processing in Golgi
- Pre-NOTCH Processing in Golgi
- Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
- NOTCH1 Intracellular Domain Regulates Transcription
- NOTCH1 Intracellular Domain Regulates Transcription
- Activated NOTCH1 Transmits Signal to the Nucleus
- Activated NOTCH1 Transmits Signal to the Nucleus
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
- Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- Constitutive Signaling by NOTCH1 HD Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- Notch-HLH transcription pathway
- Defective LFNG causes SCDO3
- RUNX3 regulates NOTCH signaling
- RUNX3 regulates NOTCH signaling
- NOTCH3 Intracellular Domain Regulates Transcription
- NOTCH3 Intracellular Domain Regulates Transcription
- NOTCH4 Intracellular Domain Regulates Transcription
|
|
|
|
- Bicuspid aortic valve
- Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
|
RHOA and LRP2 |
ras homolog family member A |
LDL receptor related protein 2 |
- GPVI-mediated activation cascade
- Axonal growth inhibition (RHOA activation)
- Rho GTPase cycle
- PI3K/AKT activation
- Axonal growth stimulation
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- G beta:gamma signalling through PI3Kgamma
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- EPHA-mediated growth cone collapse
- EPHA-mediated growth cone collapse
- PCP/CE pathway
- G alpha (12/13) signalling events
- Sema4D mediated inhibition of cell attachment and migration
- Sema4D induced cell migration and growth-cone collapse
- Sema4D induced cell migration and growth-cone collapse
- VEGFA-VEGFR2 Pathway
- RHO GTPases activate PKNs
- RHO GTPases activate CIT
- RHO GTPases activate CIT
- RHO GTPases activate KTN1
- RHO GTPases Activate ROCKs
- RHO GTPases Activate ROCKs
- RHO GTPases Activate Formins
- RHO GTPases Activate Rhotekin and Rhophilins
- RHO GTPases Activate Rhotekin and Rhophilins
- Ovarian tumor domain proteases
- ERBB2 Regulates Cell Motility
- Neutrophil degranulation
- PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
- SLIT2:ROBO1 increases RHOA activity
|
- Vitamin D (calciferol) metabolism
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- Retinoid metabolism and transport
|
|
- Urokinase
- Insulin Human
- Insulin Pork
- Gentamicin
|
|
- Donnai-Barrow syndrome; Faciooculoacousticorenal syndrome
|
RHOA and AKAP13 |
ras homolog family member A |
A-kinase anchoring protein 13 |
- GPVI-mediated activation cascade
- Axonal growth inhibition (RHOA activation)
- Rho GTPase cycle
- PI3K/AKT activation
- Axonal growth stimulation
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- G beta:gamma signalling through PI3Kgamma
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- EPHA-mediated growth cone collapse
- EPHA-mediated growth cone collapse
- PCP/CE pathway
- G alpha (12/13) signalling events
- Sema4D mediated inhibition of cell attachment and migration
- Sema4D induced cell migration and growth-cone collapse
- Sema4D induced cell migration and growth-cone collapse
- VEGFA-VEGFR2 Pathway
- RHO GTPases activate PKNs
- RHO GTPases activate CIT
- RHO GTPases activate CIT
- RHO GTPases activate KTN1
- RHO GTPases Activate ROCKs
- RHO GTPases Activate ROCKs
- RHO GTPases Activate Formins
- RHO GTPases Activate Rhotekin and Rhophilins
- RHO GTPases Activate Rhotekin and Rhophilins
- Ovarian tumor domain proteases
- ERBB2 Regulates Cell Motility
- Neutrophil degranulation
- PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
- SLIT2:ROBO1 increases RHOA activity
|
- NRAGE signals death through JNK
- Rho GTPase cycle
- G alpha (12/13) signalling events
|
|
|
|
|
RHOA and PKN2 |
ras homolog family member A |
protein kinase N2 |
- GPVI-mediated activation cascade
- Axonal growth inhibition (RHOA activation)
- Rho GTPase cycle
- PI3K/AKT activation
- Axonal growth stimulation
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- G beta:gamma signalling through PI3Kgamma
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- EPHA-mediated growth cone collapse
- EPHA-mediated growth cone collapse
- PCP/CE pathway
- G alpha (12/13) signalling events
- Sema4D mediated inhibition of cell attachment and migration
- Sema4D induced cell migration and growth-cone collapse
- Sema4D induced cell migration and growth-cone collapse
- VEGFA-VEGFR2 Pathway
- RHO GTPases activate PKNs
- RHO GTPases activate CIT
- RHO GTPases activate CIT
- RHO GTPases activate KTN1
- RHO GTPases Activate ROCKs
- RHO GTPases Activate ROCKs
- RHO GTPases Activate Formins
- RHO GTPases Activate Rhotekin and Rhophilins
- RHO GTPases Activate Rhotekin and Rhophilins
- Ovarian tumor domain proteases
- ERBB2 Regulates Cell Motility
- Neutrophil degranulation
- PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
- SLIT2:ROBO1 increases RHOA activity
|
- RHO GTPases activate PKNs
|
|
|
|
|
RHOG and DOCK1 |
ras homolog family member G |
dedicator of cytokinesis 1 |
- GPVI-mediated activation cascade
- PIP3 activates AKT signaling
- Rho GTPase cycle
- Constitutive Signaling by Aberrant PI3K in Cancer
- RHO GTPases activate KTN1
- Neutrophil degranulation
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
- Regulation of actin dynamics for phagocytic cup formation
- DCC mediated attractive signaling
- DCC mediated attractive signaling
- VEGFA-VEGFR2 Pathway
- PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
- FCGR3A-mediated phagocytosis
- Factors involved in megakaryocyte development and platelet production
|
|
|
|
|
RHOG and ELMO1 |
ras homolog family member G |
engulfment and cell motility 1 |
- GPVI-mediated activation cascade
- PIP3 activates AKT signaling
- Rho GTPase cycle
- Constitutive Signaling by Aberrant PI3K in Cancer
- RHO GTPases activate KTN1
- Neutrophil degranulation
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
- Nef and signal transduction
- Regulation of actin dynamics for phagocytic cup formation
- VEGFA-VEGFR2 Pathway
- PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
- FCGR3A-mediated phagocytosis
|
|
|
|
|
ARHGDIA and BAK1 |
Rho GDP dissociation inhibitor alpha |
BCL2 antagonist/killer 1 |
- Axonal growth inhibition (RHOA activation)
- Rho GTPase cycle
- Axonal growth stimulation
|
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
|
|
|
|
ARNT and HEY1 |
aryl hydrocarbon receptor nuclear translocator |
hes related family bHLH transcription factor with YRPW motif 1 |
- Regulation of gene expression by Hypoxia-inducible Factor
- PPARA activates gene expression
- Phase I - Functionalization of compounds
- Endogenous sterols
- Xenobiotics
- Aryl hydrocarbon receptor signalling
|
- NOTCH1 Intracellular Domain Regulates Transcription
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- RUNX2 regulates osteoblast differentiation
- NOTCH3 Intracellular Domain Regulates Transcription
- NOTCH4 Intracellular Domain Regulates Transcription
|
|
|
|
|
ARNT and HEY2 |
aryl hydrocarbon receptor nuclear translocator |
hes related family bHLH transcription factor with YRPW motif 2 |
- Regulation of gene expression by Hypoxia-inducible Factor
- PPARA activates gene expression
- Phase I - Functionalization of compounds
- Endogenous sterols
- Xenobiotics
- Aryl hydrocarbon receptor signalling
|
- NOTCH1 Intracellular Domain Regulates Transcription
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- RUNX2 regulates osteoblast differentiation
- NOTCH3 Intracellular Domain Regulates Transcription
- NOTCH4 Intracellular Domain Regulates Transcription
|
|
|
|
|
ARNTL and HIF1A |
aryl hydrocarbon receptor nuclear translocator like |
hypoxia inducible factor 1 subunit alpha |
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- PPARA activates gene expression
- Circadian Clock
|
- Regulation of gene expression by Hypoxia-inducible Factor
- Cellular response to hypoxia
- Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
- NOTCH1 Intracellular Domain Regulates Transcription
- Circadian Clock
- Ub-specific processing proteases
- Interleukin-4 and Interleukin-13 signaling
- PTK6 Expression
- PTK6 promotes HIF1A stabilization
- Neddylation
|
|
- Carvedilol
- 2-Methoxyestradiol
- N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE
|
|
|
ARNTL and HLF |
aryl hydrocarbon receptor nuclear translocator like |
HLF transcription factor, PAR bZIP family member |
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- PPARA activates gene expression
- Circadian Clock
|
|
|
|
|
|
ARNTL and RXRA |
aryl hydrocarbon receptor nuclear translocator like |
retinoid X receptor alpha |
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- PPARA activates gene expression
- Circadian Clock
|
- RORA activates gene expression
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- Recycling of bile acids and salts
- Synthesis of bile acids and bile salts
- Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
- Synthesis of bile acids and bile salts via 27-hydroxycholesterol
- PPARA activates gene expression
- PPARA activates gene expression
- Carnitine metabolism
- Regulation of pyruvate dehydrogenase (PDH) complex
- Endogenous sterols
- Transcriptional activation of mitochondrial biogenesis
- Activation of gene expression by SREBF (SREBP)
- Transcriptional regulation of white adipocyte differentiation
- Transcriptional regulation of white adipocyte differentiation
- Nuclear Receptor transcription pathway
- Regulation of lipid metabolism by PPARalpha
- Circadian Clock
- SUMOylation of intracellular receptors
- Signaling by Retinoic Acid
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
- NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake
- NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose
- Transcriptional regulation of granulopoiesis
- Transcriptional regulation of granulopoiesis
- NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
- NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis
|
|
- Alpha-Linolenic Acid
- Adapalene
- Bexarotene
- Rosiglitazone
- Acitretin
- Alitretinoin
- Etodolac
- Tretinoin
- Etretinate
- Bezafibrate
- Alfacalcidol
- Phthalic Acid
- Doconexent
- Oleic Acid
- Arachidonic Acid
- (5BETA)-PREGNANE-3,20-DIONE
- 2-chloro-5-nitro-N-phenylbenzamide
- 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE
- 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
- tributylstannanyl
|
|
|